ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

TALS Talaris Therapeutics Inc

2.72
0.00 (0.00%)
시간외 단일가
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Talaris Therapeutics Inc TALS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.72 09:00:00
개장가 저가 고가 종가 전일 종가
2.72
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
20/04/202405:05EDGAR2Form ARS - Annual Report to Security Holders
20/04/202405:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/04/202405:02EDGAR2Form DEF 14A - Other definitive proxy statements
20/03/202406:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/03/202406:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19/03/202420:09EDGAR2Form 8-K - Current report
21/11/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202308:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202306:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/10/202305:15EDGAR2Form SC 13D/A - General statement of acquisition of..
28/10/202306:17EDGAR2Form 8-K - Current report
28/10/202305:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/10/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202305:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202310:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/10/202306:47GLOBETalaris Therapeutics Announces Stockholder Approval of..
11/10/202305:32EDGAR2Form 425 - Prospectuses and communications, business..
11/10/202305:30EDGAR2Form 8-K/A - Current report: [Amend]
07/10/202309:01DJNStocks to Watch: Shift Technologies, Talaris Therapeutics,..
07/10/202306:30EDGAR2Form 8-K - Current report
07/10/202306:27EDGAR2Form 425 - Prospectuses and communications, business..
07/10/202306:26EDGAR2Form 8-K - Current report
07/10/202306:09GLOBETalaris Therapeutics Declares Special Dividend In Connection..
04/10/202321:30GLOBENew York Blood Center Enterprises Acquires Commercial-Scale..
26/09/202321:24EDGAR2Form 425 - Prospectuses and communications, business..
26/09/202321:21EDGAR2Form 8-K - Current report
15/09/202319:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/09/202305:28EDGAR2Form S-4/A - Registration of securities, business..
13/09/202322:14EDGAR2Form 425 - Prospectuses and communications, business..
13/09/202322:13EDGAR2Form 8-K - Current report
12/09/202305:47EDGAR2Form S-4/A - Registration of securities, business..
28/08/202320:38EDGAR2Form 425 - Prospectuses and communications, business..
26/08/202305:34EDGAR2Form S-4/A - Registration of securities, business..
14/08/202320:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/06/202320:30GLOBETalaris Therapeutics and Tourmaline Bio Announce Merger..
26/05/202320:00GLOBETalaris Therapeutics Announces Leadership Transition

최근 히스토리

Delayed Upgrade Clock